RG
RCEL icon

Redmile Group’s Avita Medical RCEL Stock Holding History

Redmile Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-672,411
Closed -$8.05M – 72
2021
Q4 		$8.05M Sell
672,411
-673,806
-50% -$10.3M 0.18% 61
2021
Q3 		$23.9M Sell
1,346,217
-64,900
-5% -$1.22M 0.42% 51
2021
Q2 		$29M Sell
1,411,117
-257,210
-15% -$5.07M 0.43% 56
2021
Q1 		$33.1M Sell
1,668,327
-39,059
-2% -$908K 0.47% 56
2020
Q4 		$31.7M Sell
1,707,386
-72,200
-4% -$1.58M 0.38% 57
2020
Q3 		$44.8M Buy
+1,779,586
New +$44.4M 0.82% 39

Other funds holding RCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Redmile Group's RCEL Position: Q1 2022 in Review

Redmile Group sold out of Avita Medical (RCEL) in Q1 2022, closing a stake of 672,411 shares — an estimated $8.05M sold.

Redmile Group first reported a position in RCEL in Q3 2020 and held it in 6 quarters. The position peaked at $44.8M in Q3 2020. 69 funds tracked by Wall St. Rank hold RCEL as of Q1 2022.

  • Redmile Group reported no remaining Avita Medical position as of Q1 2022 after selling out during the quarter.
  • Redmile Group sold 672,411 Avita Medical shares in Q1 2022, an estimated $8.05M.
  • Redmile Group first reported a position in Avita Medical in Q3 2020 and held it in 6 quarters.
  • Redmile Group's Avita Medical position peaked at $44.8M in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Avita Medical as of Q1 2022.

Based on Redmile Group's 13F filing for Q1 2022, filed 16 May 2022.